Delta Lloyd’s Bristol-Myers Squibb BMY Stock Holding History

Delta Lloyd’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$9.92M	Buy	178,074 +10,670	+6%	+$581K	0.28%	106
2017 Q1	$9.1M	Buy	167,404 +9,802	+6%	+$538K	0.27%	109
2016 Q4	$9.21M	Buy	157,602 +35,339	+29%	+$1.93M	0.29%	103
2016 Q3	$6.59M	Buy	122,263 +10,306	+9%	+$662K	0.2%	108
2016 Q2	$8.23M	Sell	111,957 -190	-0.2%	-$13.4K	0.28%	98
2016 Q1	$7.16M	Sell	112,147 -11,002	-9%	-$694K	0.24%	106
2015 Q4	$8.47M	Sell	123,149 -1,441	-1%	-$95.2K	0.29%	81
2015 Q3	$7.38M	Buy	124,590 +10,328	+9%	+$655K	0.24%	108
2015 Q2	$7.6M	Buy	114,262 +42,818	+60%	+$2.82M	0.24%	104
2015 Q1	$4.61M	Sell	71,444 -2,476	-3%	-$155K	0.14%	109
2014 Q4	$4.36M	Buy	73,920 +6,410	+9%	+$361K	0.13%	118
2014 Q3	$3.46M	Buy	67,510 +3,634	+6%	+$182K	0.03%	127
2014 Q2	$3.1M	Buy	63,876 +6,302	+11%	+$311K	0.1%	127
2014 Q1	$2.99M	Buy	57,574 +4,584	+9%	+$244K	0.1%	115
2013 Q4	$2.82M	Sell	52,990 -119,552	-69%	-$6.09M	0.1%	124
2013 Q3	$7.99M	Sell	172,542 -18,727	-10%	-$822K	0.31%	74
2013 Q2	$8.55M	Buy	+191,269	New	+$8.3M	0.33%	61

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Delta Lloyd's BMY Position: Q2 2017 in Review

Delta Lloyd increased its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2017, buying an estimated $581K and bringing the position to 178,074 shares worth $9.92M. The position accounts for 0.28% of the portfolio, ranked #106.

Delta Lloyd first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Delta Lloyd held 178,074 shares of Bristol-Myers Squibb worth $9.92M as of Q2 2017.
Delta Lloyd bought 10,670 Bristol-Myers Squibb shares in Q2 2017, an estimated $581K.
Bristol-Myers Squibb made up 0.28% of Delta Lloyd's portfolio in Q2 2017, its #106 holding.
Delta Lloyd first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.